Performant Healthcare PE Ratio 2011-2024 | PHLT
Current and historical p/e ratio for Performant Healthcare (PHLT) from 2011 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Performant Healthcare PE ratio as of April 01, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Performant Healthcare PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-03-31 | 2.96 | 0.00 | |
| 2024-12-31 | 3.02 | $-0.12 | 0.00 |
| 2024-09-30 | 3.74 | $-0.10 | 0.00 |
| 2024-06-30 | 2.90 | $-0.08 | 0.00 |
| 2024-03-31 | 2.94 | $-0.09 | 0.00 |
| 2023-12-31 | 3.13 | $-0.10 | 0.00 |
| 2023-09-30 | 2.26 | $-0.12 | 0.00 |
| 2023-06-30 | 2.70 | $-0.13 | 0.00 |
| 2023-03-31 | 3.40 | $-0.12 | 0.00 |
| 2022-12-31 | 3.61 | $-0.08 | 0.00 |
| 2022-09-30 | 1.85 | $-0.12 | 0.00 |
| 2022-06-30 | 2.63 | $-0.13 | 0.00 |
| 2022-03-31 | 3.11 | $-0.12 | 0.00 |
| 2021-12-31 | 2.41 | $-0.18 | 0.00 |
| 2021-09-30 | 3.96 | $-0.07 | 0.00 |
| 2021-06-30 | 3.75 | $0.00 | 0.00 |
| 2021-03-31 | 2.15 | $-0.10 | 0.00 |
| 2020-12-31 | 0.88 | $-0.25 | 0.00 |
| 2020-09-30 | 0.94 | $-0.39 | 0.00 |
| 2020-06-30 | 0.65 | $-0.58 | 0.00 |
| 2020-03-31 | 0.90 | $-0.57 | 0.00 |
| 2019-12-31 | 1.02 | $-0.50 | 0.00 |
| 2019-09-30 | 1.10 | $-0.53 | 0.00 |
| 2019-06-30 | 1.05 | $-0.53 | 0.00 |
| 2019-03-31 | 2.07 | $-0.48 | 0.00 |
| 2018-12-31 | 2.25 | $-0.16 | 0.00 |
| 2018-09-30 | 2.12 | $-0.05 | 0.00 |
| 2018-06-30 | 2.15 | $-0.05 | 0.00 |
| 2018-03-31 | 3.00 | $-0.03 | 0.00 |
| 2017-12-31 | 1.65 | $-0.25 | 0.00 |
| 2017-09-30 | 1.82 | $-0.50 | 0.00 |
| 2017-06-30 | 2.09 | $-0.36 | 0.00 |
| 2017-03-31 | 2.93 | $-0.28 | 0.00 |
| 2016-12-31 | 2.35 | $-0.22 | 0.00 |
| 2016-09-30 | 2.95 | $0.06 | 49.17 |
| 2016-06-30 | 1.62 | $0.06 | 27.00 |
| 2016-03-31 | 1.70 | $0.04 | 42.50 |
| 2015-12-31 | 1.79 | $-0.05 | 0.00 |
| 2015-09-30 | 2.42 | $-0.14 | 0.00 |
| 2015-06-30 | 3.24 | $-0.14 | 0.00 |
| 2015-03-31 | 3.40 | $-0.03 | 0.00 |
| 2014-12-31 | 6.65 | $0.19 | 35.00 |
| 2014-09-30 | 8.08 | $0.40 | 20.20 |
| 2014-06-30 | 10.10 | $0.72 | 14.03 |
| 2014-03-31 | 9.05 | $0.83 | 10.90 |
| 2013-12-31 | 10.30 | $0.74 | 13.92 |
| 2013-09-30 | 10.90 | $0.70 | 15.57 |
| 2013-06-30 | 11.59 | $0.52 | 22.29 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.232B | $0.123B |
| Performant Financial Corporation is engaged in providing technology-enabled recovery and related analytics services in the United States. The company's services help identify and recover delinquent or defaulted assets and improper payments for both government and private clients. Services offered by the company includes financial asset recovery, risk management, audit and recovery cost containment and fraud, waste and abuse marketplace. Performant provides its services on an outsourced basis. It provides services to clients in a range of different markets which includes student lending and healthcare, delinquent state taxes and federal Treasury and other receivables. Performant Financial Corporation is headquartered in Livermore, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $146.516B | 27.37 |
| Elevance Health (ELV) | United States | $98.469B | 13.19 |
| CVS Health (CVS) | United States | $85.419B | 12.50 |
| Cencora (COR) | United States | $53.926B | 19.57 |
| DiDi Global (DIDIY) | China | $23.525B | 0.00 |
| Natera (NTRA) | United States | $19.117B | 0.00 |
| BioMerieux (BMXMF) | France | $14.914B | 0.00 |
| ICON (ICLR) | Ireland | $14.132B | 12.84 |
| Solventum (SOLV) | United States | $13.154B | 12.27 |
| Revvity (RVTY) | United States | $12.712B | 21.59 |
| Avantor (AVTR) | United States | $11.045B | 16.21 |
| CochLear (CHEOY) | Australia | $10.877B | 0.00 |
| Doximity (DOCS) | United States | $10.834B | 56.34 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $10.609B | 0.00 |
| Viatris (VTRS) | United States | $10.397B | 3.29 |
| Medpace Holdings (MEDP) | United States | $9.283B | 24.12 |
| Sonic Healthcare (SKHHY) | Australia | $7.768B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.697B | 14.59 |
| HealthEquity (HQY) | United States | $7.644B | 37.60 |
| Bausch + Lomb (BLCO) | Canada | $5.111B | 23.39 |
| Amplifon S.p.A (AMFPF) | Italy | $4.961B | 26.19 |
| Organon (OGN) | United States | $3.841B | 3.91 |
| Alignment Healthcare (ALHC) | United States | $3.572B | 0.00 |
| Sotera Health (SHC) | United States | $3.305B | 19.11 |
| BrightSpring Health Services (BTSG) | United States | $3.165B | 32.89 |
| Surgery Partners (SGRY) | United States | $3.031B | 34.93 |
| Concentras Parent (CON) | United States | $2.781B | 14.47 |
| GeneDx Holdings (WGS) | United States | $2.486B | 295.22 |
| Ardent Health Partners (ARDT) | United States | $1.963B | 0.00 |
| Progyny (PGNY) | United States | $1.908B | 42.15 |
| Agilon Health (AGL) | United States | $1.785B | 0.00 |
| Premier (PINC) | United States | $1.760B | 11.27 |
| PACS (PACS) | United States | $1.713B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.692B | 36.75 |
| Teladoc Health (TDOC) | United States | $1.382B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.243B | 10.42 |
| Establishment Labs Holdings (ESTA) | $1.177B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $1.031B | 0.00 |
| CareDx (CDNA) | United States | $0.984B | 16.75 |
| AMN Healthcare Services Inc (AMN) | United States | $0.934B | 7.39 |
| Embecta (EMBC) | United States | $0.741B | 5.08 |
| QDM (QDMI) | Hong Kong, SAR China | $0.526B | 13.77 |
| Auna S.A (AUNA) | Luxembourg | $0.526B | 13.94 |
| Enhabit (EHAB) | United States | $0.444B | 41.86 |
| Sonida Senior Living (SNDA) | United States | $0.441B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.403B | 0.00 |
| SBC Medicals (SBC) | United States | $0.329B | 0.00 |
| DocGo (DCGO) | United States | $0.269B | 11.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.265B | 0.00 |
| Nutex Health (NUTX) | United States | $0.256B | 5.10 |
| LifeMD (LFMD) | United States | $0.243B | 0.00 |
| Beauty Health (SKIN) | United States | $0.168B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.139B | 0.00 |
| So-Young (SY) | China | $0.098B | 0.00 |
| Biodesix (BDSX) | United States | $0.091B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.090B | 0.00 |
| OncoCyte (OCX) | United States | $0.088B | 0.00 |
| Oncology Institute (TOI) | United States | $0.086B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.075B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.065B | 0.00 |
| NeueHealth (NEUE) | United States | $0.056B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.026B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.024B | 0.00 |
| ModivCare (MODV) | United States | $0.019B | 6.57 |
| SeaStar Medical Holding (ICU) | United States | $0.011B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.010B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.010B | 0.00 |
| KindlyMD (KDLY) | United States | $0.010B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.004B | 0.00 | |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.001B | 0.00 |
| Aclarion (ACON) | United States | $0.000B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |